Literature DB >> 7140337

Hypermetabolic low triiodothyronine syndrome of burn injury.

R A Becker, G M Vaughan, M G Ziegler, L G Seraile, I W Goldfarb, E H Mansour, W F McManus, B A Pruitt, A D Mason.   

Abstract

The free tetraiodothyronine index (FT4I) and free triiodothyronine index (FT3I) in burn patients represented the serum levels of free (dialyzable) T4 and free T3, respectively. FT4I and FT3I were lower with greater burn size and were lower in nonsurvivors than expected for the burn size. there was no compensatory elevation of basal or releasing hormone-stimulated thyrotrophin (TSH) concentrations. Reverse T3 was higher with greater burn size. T3 treatment restored FT3I but did not affect mortality or resting metabolic rate (MR) measured in survivors, compared with placebo therapy. Whereas the hypermetabolic response to burn injury appeared t be independent of thyroid hormones, MR was correlated positively with burn size and with elevated plasma norepinephrine and epinephrine concentrations for several weeks after injury. Lack of augmented TSH concentrations, absence of low plasma reverse T3, and presence of hypermetabolism suggest that the reduced plasma free T3 does not indicate functional hypothyroidism, but may represent an adaptation to the assumption of metabolic control by the sympathetic nervous system.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7140337     DOI: 10.1097/00003246-198212000-00014

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  30 in total

Review 1.  The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment?

Authors:  N Stathatos; L Wartofsky
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

Review 2.  "Non-thyroidal illness syndrome" is functional central hypothyroidism, and if severe, hormone replacement is appropriate in light of present knowledge.

Authors:  L J DeGroot
Journal:  J Endocrinol Invest       Date:  2003-12       Impact factor: 4.256

3.  Low triiodothyronine syndrome: a prognostic marker for outcome in sepsis?

Authors:  Stefanie Meyer; Philipp Schuetz; Melanie Wieland; Charly Nusbaumer; Beat Mueller; Mirjam Christ-Crain
Journal:  Endocrine       Date:  2011-01-06       Impact factor: 3.633

4.  Relationships between thyroid function and autoimmunity with metabolic derangement at the onset of type 1 diabetes: a cross-sectional and longitudinal study.

Authors:  C Balsamo; S Zucchini; G Maltoni; A Rollo; A L Martini; L Mazzanti; A Pession; A Cassio
Journal:  J Endocrinol Invest       Date:  2015-02-27       Impact factor: 4.256

Review 5.  Thyroid and aging.

Authors:  Mouhammed Habra; Nicholas J Sarlis
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

6.  The dilemma of the nonthyroidal illness syndrome.

Authors:  Ronald M Lechan
Journal:  Acta Biomed       Date:  2008-12

7.  Effects of substitution and high-dose thyroid hormone therapy on deiodination, sulfoconjugation, and tissue thyroid hormone levels in prolonged critically ill rabbits.

Authors:  Yves Debaveye; Björn Ellger; Liese Mebis; Theo J Visser; Veerle M Darras; Greet Van den Berghe
Journal:  Endocrinology       Date:  2008-05-01       Impact factor: 4.736

8.  Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement.

Authors:  Jacqueline Jonklaas; Antonio C Bianco; Andrew J Bauer; Kenneth D Burman; Anne R Cappola; Francesco S Celi; David S Cooper; Brian W Kim; Robin P Peeters; M Sara Rosenthal; Anna M Sawka
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

Review 9.  Metabolic implications of severe burn injuries and their management: a systematic review of the literature.

Authors:  Bishara S Atiyeh; S William A Gunn; Saad A Dibo
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

Review 10.  Nonthyroidal illness syndrome in children.

Authors:  Seth D Marks
Journal:  Endocrine       Date:  2009-09-25       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.